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Abstract
Background New pharmacovigilance legislation allows con-
sumers to report adverse drug reactions (ADRs) directly to
competent authorities in all European Union countries. Con-
sumer reporting is available in Portugal since July 2012. In
2013, the National Pharmacovigilance System (SNF) had re-
ceived 3461 spontaneous ADR reports, of which only 1.4 %
(n = 50) were from consumers. Consumer reporting could be
one opportunity to reduce underreporting.
Aim The aim of this study was to describe the attitudes and
knowledge of the general public regarding spontaneous
reporting and the reasons and opinions that can influence con-
sumers’ ADR underreporting.
Methods A descriptive-correlational study was performed
looking for consumers’ attitudes and knowledge regarding
spontaneous reporting. A 6-month survey was conducted
from June to November 2013 in general adult consumers from
a community pharmacy in Coimbra, Portugal, who used pre-
scribed medicines or over-the-counter (OTC) drugs. Attitudes
and opinions were surveyed by personal interview in a closed-
answer questionnaire using a Likert scale. Questionnaires
from healthcare professionals or incomplete ones were not
considered. Data were analyzed using descriptive statistics,
chi-square (χ2) tests, and Spearman’s correlation coefficients.
Results One thousand eighty-four questionnaires were col-
lected (response rate of 81.1 %) and 948 completed were
selected for analysis. Of the respondents, 44.1 % never heard
about SNF. Younger people and those with a higher education
were significantly more likely to be aware of SNF. Only one
consumer had previously reported directly anADR. Reporting
ADRs indirectly through a healthcare professional (HCP) was
preferred by 62.4 %. The main reasons for consumers
reporting spontaneous ADRwould be the severity of reactions
(81.1 % agreed or strongly agreed) and worries about their
situation (73.4 % agreed or strongly agreed). Only weak and
moderate correlations were found between studied
statements..
Conclusions Consumers are more likely to do spontaneous
report about severe reactions or if they are worried about the
symptoms. Tailored and proactive information on ADR
reporting and educational interventions on consumers could
increase the number of reports from consumers in Portugal.
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Introduction
Voluntary adverse drug reaction (ADR) reporting is one of the
most versatile pharmacovigilance methods, because, among oth-
er advantages, it covers the entire population as well as all drugs
throughout their commercial life [1], being also a method that
provides the highest volume of information with relatively lower
maintenance cost than other pharmacovigilance methods [2].
The new European legislation about pharmacovigilance
that came into force last July 2012 [3] is the biggest change
in the humanmedicine regulation in the EuropeanUnion (EU)
since 1995. The importance of direct consumer reporting has
been highlighted by this new European legislation that guides
member states to take all appropriate measures to encourage
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